| CMF-00721 | HMCN1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 7 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-02731 | ABCA5 | up-regulates | SMAD1 | activates | R-1484 | 21 | 1 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-09350 | SPTA1 | down-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-09456 | ZIC4 | up-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-10568 | LRBA | up-regulates | SMAD1 | activates | R-1484 | 21 | 5 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-13644 | FMN1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 11 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-15701 | DCHS2 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-15820 | GRM3 | up-regulates | SMAD1 | activates | R-1484 | 21 | 1 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-16618 | KRTAP5-4 | up-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-18516 | LAMA1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 6 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-18722 | MPP7 | down-regulates | SMAD1 | activates | R-1484 | 21 | 5 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-21430 | GRIK3 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-23347 | CCDC132 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-24082 | TP53 | down-regulates | SMAD1 | activates | R-1484 | 21 | 12 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-24562 | SEMA3C | down-regulates | SMAD1 | activates | R-1484 | 21 | 6 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-28673 | PCNX | down-regulates | SMAD1 | activates | R-1484 | 21 | 3 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
| CMF-30385 | RNF130 | down-regulates | SMAD1 | activates | R-1484 | 21 | 3 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |